课题基金 / 基金详情

China Health and Retirement Longitudinal Study

China Health and Retirement Longitudinal Study
中国健康与养老追踪研究
批准号:
8866261
负责人:
JOHN A STRAUSS
金额:
$200.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-15 至 2019-04-30

项目摘要

项目成果

JOHN A STRAUSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): This competitive, renewal proposal is to fund waves 3 and 4 of the China Health and Retirement Study (CHARLS). CHARLS is directly patterned on the HRS and its sister surveys in England, Europe, Japan, Indonesia and South Korea. The new HRS surveys in India (LASI) and Thailand (HART) have used the CHARLS survey modules as the starting point of their modules. The CHARLS national baseline survey was conducted in 2011-12. It is a nationally representative survey that includes one person per household aged 45 years of age or older and their spouse (totaling 17,708 individuals) living in 10,257 households in 450 villages/urban communities in 150 counties/districts in 28 of China's 30 provinces excluding Tibet. The CHARLS national baseline data have recently been released publicly, 11 months after completing field operations. Wave 2 was fielded in the summer and fall of 2013. It will be publicly released by fall of 2014. Some 91% of wave 1 respondents were re-contacted in wave 2, plus a small refresher sample of new respondents who had reached age 45 since wave 1, plus some households that we were unable to contact in the baseline, that we found and interviewed in wave 2. A special wave to collect life history data will be fielded in the summer of 2014, using resources from the National Natural Science Foundation of China (NSFC) and other sources. We want to continue CHARLS, getting the full benefit of building a publicly available panel data set, by fielding CHARLS for 2 additional waves, 3 and 4, thus establishing CHARLS as an ongoing biennial panel survey, like the HRS and its other sister surveys in Europe and Asia. An HRS-type survey in China has been past overdue. The importance of research on aging is recognized world-wide, where numerous high-quality surveys modeled after the US Health and Retirement Survey (HRS) and funded by National Institute on Aging (NIA), are ongoing. Developing countries, especially in Asia, are going through rapid demographic and health transitions in which the elderly become much more prominent and the nature of health problems changes from infectious diseases, which affect mainly the young, to chronic diseases, which affect the elderly. Moreover, they are undergoing the aging process at much lower income levels than was the experience in industrial countries. China is a prominent example. China has more elderly than any country in the world and is one of the fastest-aging countries in the world today. China's population is aging at income levels far lower than was true for industrial countries and aging faster than other currently developing countries. Compared to most other countries with Health and Retirement Studies, China is much more rural, with lower levels of schooling among the elderly, lower levels of public services available, and an enhanced importance of the family for social security. Given these major challenges facing China to meet the needs of a rapidly aging population, there is significant value in continuing to make a high quality panel data set on aging available to international researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
China Health and Retirement Longitudinal study
  • 批准号:
    10467999
  • 项目类别:
  • 资助金额:
    $90.2万
  • 财政年份:
    2020
  • 负责人:
    JOHN A STRAUSS
  • 依托单位:
China Health and Retirement Longitudinal study
  • 批准号:
    10183087
  • 项目类别:
  • 资助金额:
    $176.68万
  • 财政年份:
    2020
  • 负责人:
    JOHN A STRAUSS
  • 依托单位:
China Health and Retirement Longitudinal study
  • 批准号:
    10626117
  • 项目类别:
  • 资助金额:
    $43.41万
  • 财政年份:
    2020
  • 负责人:
    JOHN A STRAUSS
  • 依托单位:
Influences of Early and Later Life Events on Cognition and All-Cause Dementia in China
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: